Publications

5677 Results

A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART) SWOG S1609: The small cell carcinoma of the ovary, hypercalcemic type cohort #49

Authors
Y Chae;M Othus;S Patel;R Aljumaily;K Win;T Pejovic;S Thomas;L Il-Young Chung;C McLeod;H Chen;E Sharon;H Streicher;C Ryan;CD Blanke;R Kurzrock
Journal / Conference
AACR Annual Meeting (April 14-19, 2023, Orlando, FL, poster
Year
2023
Research Committee(s)
Early Therapeutics and Rare Cancers
Study Number(s)
S1609

Adjuvant everolimus in patients (pts) with completely resected very high-risk renal cell cancer (RCC) and clear cell histology: results from the phase III placebo-controlled SWOG S0931 (EVEREST) trial

Authors
PN Lara;C Tangen;E Heath;M Stein;M Meng;A Alva;S Pal;I Puzanov;J Clark;T Choueiri;N Agarwal;R Uzzo;N Haas;M Plets;U Vaishampayan;B Shuch;IM Thompson;C Ryan
Journal / Conference
Annals of Oncology VOLUME 34, SUPPLEMENT 2, S1015; ESMO (October 20-24, 2023, Madrid, Spain), poster
Year
2023
Research Committee(s)
Genitourinary
Study Number(s)
S0931

Clinical outcomes and translational analysis of DART S1609: the thyroid cancer cohort; PD-1+ PD-L1+ TIL correlated with favorable survival

Authors
YK Chae;Y Lu;S Patel;C Rodriguez;A Onitilo;A Mattour;I Rybkin;S Fenton;L Il-Young Chung;H Kim;M Othus;E Parra;J Zhang;L Gomez;C Fernandez;L Soto;H Chen;G Manyam;D Duose;R Luthra;J Zhang;G Al-Atrash;I Wistuba;J Lee;J Zhang;C Haymaker;C McLeod;H Chen;E Sharon;C Ryan;G Lopez;M Plets;CD Blanke;R Kurzrock
Journal / Conference
SITC Annual Meeting (Nov. 1-5, 2023, San Diego, CA), poster
Year
2023
Research Committee(s)
Early Therapeutics and Rare Cancers
Study Number(s)
S1609

Dual Prognostic Classification of Triple-Negative Breast Cancer by DNA Damage Immune Response and Homologous Recombination Deficiency

Authors
S Stecklein;W Barlow;L Pusztai;K Timms;R Kennedy;G Logan;R Seitz;S Badve;Y Gokmen-Polar;P Porter;H Linden;D Tripathy;G Hortobagyi;A Godwin;A Godwin;A Thompson;D Hayes;P Sharma
Journal / Conference
JCO Precision Oncology Sep:7:e2300197. doi: 10.1200/PO.23.00197
Year
2023
Research Committee(s)
Breast
PMID
PMID37972336
PMC
PMC10681491
Study Number(s)
SWOG-9313

Mixed-methods analysis of physician genomic confidence in the pre-implementation phase of the cluster randomized trial evaluating genomic tumor boards (SWOG S2108CD, NCT05455606)

Authors
M Trivedi;J Rueter;J Unger;K Arnold;S Colby;A Michel;A Taboada;L Graham;K Reed;J Fischer;B Symington;S Ramsey;D Hershman
Journal / Conference
ASCO Quality Care Symposium (October 27-28, 2023, Boston, MA, poster; JCO Oncol Pract 19, 2023 (suppl 11; abstr 439)
Year
2023
Research Committee(s)
Cancer Care Delivery
Study Number(s)
S2108CD

Verification of prognostic expression biomarkers is improved by examining enriched leukemic blasts rather than mononuclear cells from acute myeloid leukemia patients

Authors
E Pogosova-Agadjanyan;X Hua;M Othus;F Appelbaum;T Chauncey;H Erba;M Fitzgibbon;J Godwin;I Jenkins;M Fang;A Moseley;J Naru;J Radich;B Willborg;C Willman;F Wu;S Meshichi;D Stirewalt
Journal / Conference
Biomarker Research Mar 16;11(1):31. doi: 10.1186/s40364-023-00461-0
Year
2023
Research Committee(s)
Leukemia
PMID
PMID36927800
PMC
PMC10022072
Study Number(s)
S0106, S0112, SWOG-9031, SWOG-9333

Clinical trial design change implementation for inclusive studies

Authors
M Espinoza Gutarra;J Aiello;R Orlowski;S Ailawadhi
Journal / Conference
Lancet Hematology Dec;10(12):e953-e954. doi: 10.1016/S2352-3026(23)00336-8
Year
2023
Research Committee(s)
Myeloma
PMID
PMID38030317
Study Number(s)
S2209

Vitamin D Insufficiency as a Risk Factor for Paclitaxel-Induced Peripheral Neuropathy in SWOG S0221

Authors
C Chen;G Zirpoli;S McCann;W Barlow;GT Budd;L Pusztai;NL Henry;A Godwin;A Thompson;C Ambrosone;K Stringer;D Hertz
Journal / Conference
Journal of the National Comprehensive Cancer Network Nov;21(11):1172-1180.e3
Year
2023
Research Committee(s)
Breast
PMID
PMID37935109
PMC
PMC10976748
Study Number(s)
S0221

Quantification of measurable residual disease using duplex sequencing in adults with acute myeloid leukemia.

Authors
L Dillon;J Higgins;H Nasif;M Othus;L Beppu;T Smith;E Schmidt;C Valentine;J Salk;B Wood;J Radich;C Hourigan
Journal / Conference
Haematologica Aug 3; doi: 10.3324/haematol.2023.283520 Online ahead of print
Year
2023
Research Committee(s)
Leukemia
PMID
PMID:37534515
PMC
PMC10081409
Study Number(s)
S0106

Intervention Nonadherence in the TrACER (S1415CD) Study: A Pragmatic Randomized Trial of a Standardized Order Entry for CSF Prescribing

Authors
DL Hershman;A Bansal;W Barlow;K Arnold;K Watabayashi;A Bell-Brown;S Sullivan;G Lyman;S Ramsey
Journal / Conference
JCO Oncology Practice Dec;19(12):1160-1167
Year
2023
Research Committee(s)
Cancer Care Delivery
PMID
PMID37788414
PMC
PMC10732502
Study Number(s)
S1415CD